U.S. market Closed. Opens in 12 hours 4 minutes

SYRS | Syros Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue9.94M14.88M23.49M15.09M1.98M2.05M1.10M317.00K317.00KN/A
Cost of Revenue2.25M2.97MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit7.68M11.91M23.49M15.09M1.98M2.05MN/AN/AN/AN/A
Operating Expenses134.18M141.24M122.91M97.39M79.72M66.35M55.79M48.28MN/AN/A
Selling, General & Admin28.28M29.30M23.04M21.32M21.48M16.16M13.89M10.46M5.73M2.51M
Research & Development105.90M111.94M99.87M76.06M58.24M50.18M41.90M37.82M24.41M10.92M
Other Operating Expenses2.49M-9.51MN/AN/A2.30M2.02MN/AN/AN/AN/A
Operating Income-126.50M-135.87M-99.42M-82.30M-77.74M-64.30M-54.69M-47.96M-29.82M-13.44M
Other Expenses / Income-38.08M41.22M12.86M-1.74M2.30M2.02M676.00K220.00K2.00K4.00K
Before Tax Income-164.57M-94.65M-86.56M-84.04M-75.44M-62.28M-54.01M-47.74M-29.82M-13.43M
Income Tax Expenses2.08M-45.35M3.91M1.79M2.55M2.02MN/AN/AN/AN/A
Net Income-164.57M-49.30M-90.47M-85.83M-75.44M-62.28M-54.01M-47.74M-29.82M-13.43M
Interest Expenses5.13M4.13M3.91M1.79MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding28.33M12.63M6.25M4.61M4.02M3.27M2.54M12.70M14.59M2.48M
Diluted Shares Outstanding28.33M12.63M6.25M4.61M4.02M3.27M2.54M12.70M14.59M2.48M
EBITDA-124.25M-130.77M-96.31M-78.84M-75.02M-62.69M-52.48M-46.47M-29.22M-13.18M
EBITDA Margin-1,250.47%-878.86%-410.06%-522.33%-3,785.02%-3,058.15%-4,766.85%-14,659.31%-9,216.40%0.00%
EBIT-157.36M-90.52M-82.65M-82.25M-72.89M-60.26M-54.01M-47.74M-29.82M-13.43M
EBIT Margin-1,583.77%-608.33%-351.89%-544.93%-3,677.49%-2,939.61%-4,905.54%-15,060.88%-9,406.31%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙